Detalhe da pesquisa
1.
Current Status of Predictive Biomarker Development in Metastatic Renal Cell Carcinoma.
Curr Oncol Rep
; 25(6): 671-677, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37000341
2.
COVID-19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020.
Int J Cancer
; 151(9): 1502-1511, 2022 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35704342
3.
How to implement the requirements of a quality assurance system for prostate cancer.
World J Urol
; 39(1): 41-47, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-31776738
4.
Current Understanding of Urachal Adenocarcinoma and Management Strategy.
Curr Oncol Rep
; 22(1): 9, 2020 Jan 27.
Artigo
Inglês
| MEDLINE | ID: mdl-31989430
5.
Analysis of Single Circulating Tumor Cells in Renal Cell Carcinoma Reveals Phenotypic Heterogeneity and Genomic Alterations Related to Progression.
Int J Mol Sci
; 21(4)2020 Feb 21.
Artigo
Inglês
| MEDLINE | ID: mdl-32098246
6.
The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical Practice.
Int J Mol Sci
; 20(17)2019 Aug 30.
Artigo
Inglês
| MEDLINE | ID: mdl-31480348
7.
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study.
Oncology
; 94 Suppl 1: 10-15, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30036867
8.
Should we use combination therapy for all advanced renal cell carcinoma?
Lancet Oncol
; 20(10): 1331-1332, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31427206
9.
Surveillance or Dynamic Sentinel Lymph-Node Biopsy in Low-Risk Clinically N0 Penile Squamous Cell Carcinoma: Single-Institution Real World Data.
Clin Genitourin Cancer
; 22(2): 544-548, 2024 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38278655
10.
A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study).
Ther Adv Med Oncol
; 16: 17588359231217958, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38264520
11.
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study.
Clin Genitourin Cancer
; 22(3): 102074, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38616147
12.
IFN-α in advanced well-differentiated neuroendocrine tumors: the neglected drug?
Future Oncol
; 14(10): 897-899, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29528242
13.
BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patients.
Tumori
; 109(4): 418-423, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36474412
14.
A multicenter phase 2 single arm study of cabozantinib in patients with advanced or unresectable renal cell carcinoma pre-treated with one immune-checkpoint inhibitor: The BREAKPOINT trial (Meet-Uro trial 03).
Tumori
; 109(1): 129-137, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36447337
15.
Laparoscopic retroperitoneal lymph-node dissection in metastatic nonseminomatous germ-cell tumors.
Eur J Surg Oncol
; 49(1): 257-262, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36031470
16.
Biomarker-driven immunotherapy for precision medicine in prostate cancer.
Per Med
; 19(1): 51-66, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34873959
17.
Optimal Choice of Adjuvant Treatment for Renal Cell Carcinoma Following Nephrectomy.
Cancer Manag Res
; 14: 3071-3081, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36275783
18.
Cabozantinib as First-line Treatment in Patients With Metastatic Collecting Duct Renal Cell Carcinoma: Results of the BONSAI Trial for the Italian Network for Research in Urologic-Oncology (Meet-URO 2 Study).
JAMA Oncol
; 8(6): 910-913, 2022 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35420628
19.
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21).
Expert Rev Anticancer Ther
; 22(1): 115-121, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34738499
20.
Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma.
Cancers (Basel)
; 13(15)2021 Jul 28.
Artigo
Inglês
| MEDLINE | ID: mdl-34359706